REVANESSE OUTLINE Trademark

Trademark Overview

On Wednesday, September 9, 2020, a trademark application was filed for REVANESSE OUTLINE with the United States Patent and Trademark Office. The USPTO has given the REVANESSE OUTLINE trademark a serial number of 90169231. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Prollenium Medical Technologies, Inc.. The REVANESSE OUTLINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of wrinkles; injectable dermal fillers; injectable gel for dermatological use for use in cosmetic surgery, wound healing and non-surgical medical cosmetic treatment procedures; syringe containing gel for dermatological use for use in cosmetic surgery, wound healing and non-surgical medical cosmetic treatment procedures
revanesse outline

General Information

Serial Number90169231
Word MarkREVANESSE OUTLINE
Filing DateWednesday, September 9, 2020
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7498087
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of wrinkles; injectable dermal fillers; injectable gel for dermatological use for use in cosmetic surgery, wound healing and non-surgical medical cosmetic treatment procedures; syringe containing gel for dermatological use for use in cosmetic surgery, wound healing and non-surgical medical cosmetic treatment procedures

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameProllenium Medical Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B1A3
CA
Party NameProllenium Medical Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B1A3
CA
Party NameProllenium Medical Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B1A3
CA

Trademark Events

Event DateEvent Description
Saturday, September 12, 2020NEW APPLICATION ENTERED
Thursday, October 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 5, 2021INQUIRY TO SUSPENSION E-MAILED
Saturday, January 16, 2021ASSIGNED TO EXAMINER
Wednesday, January 20, 2021SUSPENSION LETTER WRITTEN
Wednesday, January 20, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, January 20, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 3, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, October 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, March 27, 2022ASSIGNED TO LIE
Tuesday, October 5, 2021SUSPENSION INQUIRY WRITTEN
Thursday, March 24, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 11, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 30, 2022SUSPENSION LETTER WRITTEN
Saturday, April 30, 2022LETTER OF SUSPENSION E-MAILED
Saturday, April 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 12, 2023SUSPENSION INQUIRY WRITTEN
Thursday, January 12, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, January 12, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023SUSPENSION LETTER WRITTEN
Friday, April 21, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 27, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 1, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, February 24, 2024SUSPENSION INQUIRY WRITTEN
Saturday, February 24, 2024INQUIRY TO SUSPENSION E-MAILED
Saturday, February 24, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 4, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, May 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

outline revanesse cosmetic treatment medical surgery healing dermatological wound procedures injectable surgical